Accuray
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Wisconsin, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
1240 Deming Way, Madison, Wisconsin, 537...Phone Number
(608) 824-2800Website
www.accuray.comRevenue
$428.6 MillionStock Symbol
ARAYIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
6
1
2
1
1
1
About Accuray
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, canceRead more
Accuray Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accuray your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Accuray launches new products
Congratulate Masked Content for being promoted to Masked Content at Accuray
Click to see if Accuray had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Accuray, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Accuray recently announced quarterly report
Funding: Get notified immidiatlly once Accuray has new funding data
Check out if Accuray is spiking on competitors!
Check if Accuray has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Accuray
Find 2 more new buyers
Compare Similar Companies to Accuray
Compare insights from companies similar to Accuray, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Accuray
$428.6M
501-1,000
Public
$500M
1990
AP
Ali PervaizSenior Vice President - Chief Financial Officer
Company Profile Activity
Activity Insights
Accuray is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Accuray is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Accuray.
Accuray financials insights
Gather financial insights about Accuray, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$288M
2016
Debt
$70M
2017
Debt
$52M
Debt
$40M
2025
Debt
$50M
Accuray Tech Stack
A closer look at the technologies used by Accuray
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
Accuray has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: C#, C++, Power BI, and Python with an increased focus that include Toolchain, Windows Software, Manufacturing Operations, House-Building, Test Automation, Sustaining Engineering, and Electronic Test Equipment.
Hiring Plans
Open Position
Accuray News & Media
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
MADISON, Wis., July 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating several decisive actions that will drive a significant improvement in its financial position, a...Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions
The latest update on Accuray centers on a sharp reset in its fair value estimate, with the target reduced from US$3.88 to US$0.35. Analysts are reworking their models to reflect more cautious assumptions, and that shift is feeding directly into revised price targets and a recalibrated narrative around what is realistic for the stock. As you read on, you will see how these changing views are taking shape and what to watch to stay onAccuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer. As material...TCW Group boosts Accuray (ARAY) stake to 13.7% through loan-linked warrants
TCW Group’s Schedule 13D/A Amendment No. 2 shows 18.94M Accuray shares beneficially owned, or 13.7% of the company, via long-dated loan-related warrants.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accuray
Sign Up For FreeTo access detailed company insights
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the... Read More
